An 0 2 0 2 O
excisional 3 13 3 13 B-treatment
biopsy 14 20 14 20 I-treatment
of 21 23 21 23 O
this 24 28 24 28 O
breast 29 35 29 35 B-cancer
cancer 36 42 36 42 I-cancer

Clinical 0 8 43 51 O
or 9 11 52 54 O
radiographic 12 24 55 67 O
evidence 25 33 68 76 O
of 34 36 77 79 O
metastatic 37 47 80 90 B-cancer
disease 48 55 91 98 I-cancer
. 55 56 98 99 O
Metastatic 57 67 100 110 B-treatment
workup 68 74 111 117 I-treatment
is 75 77 118 120 O
not 78 81 121 124 O
required 82 90 125 133 O
, 90 91 133 134 O
but 92 95 135 138 O
is 96 98 139 141 O
recommended 99 110 142 153 O
for 111 114 154 157 O
patients 115 123 158 166 O
with 124 128 167 171 O
clinical 129 137 172 180 B-chronic_disease
stage 138 143 181 186 I-chronic_disease
III 144 147 187 190 I-chronic_disease
disease 148 155 191 198 I-chronic_disease

Documentation 0 13 199 212 O
of 14 16 213 215 O
mammogram 17 26 216 225 O
and 27 30 226 229 O
ultrasound 31 41 230 240 O
( 42 43 241 242 O
including 43 52 242 251 O
ductal 53 59 252 258 B-cancer
carcinoma 60 69 259 268 I-cancer
in 70 72 269 271 I-cancer
situ 73 77 272 276 I-cancer
( 78 79 277 278 I-cancer
DCIS 79 83 278 282 I-cancer
) 83 84 282 283 I-cancer
and 85 88 284 287 O
invasive 89 97 288 296 B-cancer
cancer 98 104 297 303 I-cancer
) 104 105 303 304 O
of 106 108 305 307 O
the 109 112 308 311 O
diseased 113 121 312 320 O
breast 122 128 321 327 O
performed 129 138 328 337 O
within 139 145 338 344 O
56 146 148 345 347 B-upper_bound
days 149 153 348 352 I-upper_bound
prior 154 159 353 358 I-upper_bound
to 160 162 359 361 O
registration 163 175 362 374 O

Eastern 0 7 375 382 B-clinical_variable
Cooperative 8 19 383 394 I-clinical_variable
Oncology 20 28 395 403 I-clinical_variable
Group 29 34 404 409 I-clinical_variable
( 35 36 410 411 I-clinical_variable
ECOG 36 40 411 415 I-clinical_variable
) 40 41 415 416 I-clinical_variable
performance 42 53 417 428 I-clinical_variable
status 54 60 429 435 I-clinical_variable
0 61 62 436 437 B-lower_bound
- 62 63 437 438 O
2 63 64 438 439 B-upper_bound

Female 0 6 440 446 B-gender
≥18 7 10 447 450 O
years 11 16 451 456 I-lower_bound
of 17 19 457 459 O
age 20 23 460 463 B-age

Fine 0 4 464 468 B-treatment
needle 5 11 469 475 I-treatment
aspiration 12 22 476 486 I-treatment
( 23 24 487 488 I-treatment
FNA 24 27 488 491 I-treatment
) 27 28 491 492 I-treatment
or 29 31 493 495 O
core 32 36 496 500 B-treatment
needle 37 43 501 507 I-treatment
biopsy 44 50 508 514 I-treatment
of 51 53 515 517 I-treatment
axillary 54 62 518 526 I-treatment
node 63 67 527 531 I-treatment

History 0 7 532 539 O
of 8 10 540 542 O
invasive 11 19 543 551 O
breast 20 26 552 558 B-cancer
cancer 27 33 559 565 I-cancer
or 34 36 566 568 O
contralateral 37 50 569 582 O
DCIS 51 55 583 587 B-cancer

Hormone 0 7 588 595 B-treatment
replacement 8 19 596 607 I-treatment
therapy 20 27 608 615 I-treatment
of 28 30 616 618 O
any 31 34 619 622 O
type 35 39 623 627 O
, 39 40 627 628 O
megestrol 41 50 629 638 B-treatment
acetate 51 58 639 646 I-treatment
, 58 59 646 647 O
or 60 62 648 650 O
raloxifene 63 73 651 661 B-treatment
within 74 80 662 668 O
one 81 84 669 672 B-upper_bound
week 85 89 673 677 I-upper_bound
prior 90 95 678 683 I-upper_bound
to 96 98 684 686 O
registration 99 111 687 699 O

Inflammatory 0 12 700 712 B-cancer
breast 13 19 713 719 I-cancer
cancer 20 26 720 726 I-cancer
defined 27 34 727 734 O
as 35 37 735 737 O
clinically 38 48 738 748 O
significant 49 60 749 760 O
erythema 61 69 761 769 O
of 70 72 770 772 O
the 73 76 773 776 O
breast 77 83 777 783 O
and/or 84 90 784 790 O
documented 91 101 791 801 O
dermal 102 108 802 808 O
lymphatic 109 118 809 818 O
invasion 119 127 819 827 O
( 128 129 828 829 O
not 129 132 829 832 O
direct 133 139 833 839 O
skin 140 144 840 844 O
invasion 145 153 845 853 O
by 154 156 854 856 O
tumor 157 162 857 862 B-cancer
or 163 165 863 865 O
peau 166 170 866 870 O
d 171 172 871 872 O
' 172 173 872 873 O
orange 174 180 874 880 O
without 181 188 881 888 O
erythema 189 197 889 897 O
) 197 198 897 898 O

Invasive 0 8 899 907 O
breast 9 15 908 914 B-cancer
cancer 16 22 915 921 I-cancer
is 23 25 922 924 O
estrogen 26 34 925 933 O
receptor 35 43 934 942 O
positive 44 52 943 951 O
with 53 57 952 956 O
an 58 60 957 959 O
Allred 61 67 960 966 B-clinical_variable
score 68 73 967 972 I-clinical_variable
of 74 76 973 975 O
6 77 78 976 977 B-lower_bound
, 78 79 977 978 O
7 80 81 979 980 O
or 82 84 981 983 O
8 85 86 984 985 B-upper_bound
by 87 89 986 988 O
local 90 95 989 994 O
institution 96 107 995 1006 O
standard 108 116 1007 1015 O
protocol 117 125 1016 1024 O
. 125 126 1024 1025 O
If 127 129 1026 1028 O
an 130 132 1029 1031 O
Allred 133 139 1032 1038 B-clinical_variable
Score 140 145 1039 1044 I-clinical_variable
is 146 148 1045 1047 O
not 149 152 1048 1051 O
reported 153 161 1052 1060 O
on 162 164 1061 1063 O
the 165 168 1064 1067 O
diagnostic 169 179 1068 1078 O
pathology 180 189 1079 1088 O
report 190 196 1089 1095 O
, 196 197 1095 1096 O
ER 198 200 1097 1099 B-clinical_variable
positivity 201 211 1100 1110 I-clinical_variable
in 212 214 1111 1113 O
> 215 216 1114 1115 O
66 217 219 1116 1118 B-lower_bound
% 219 220 1118 1119 I-lower_bound
cells 221 226 1120 1125 I-lower_bound

Isolated 0 8 1126 1134 O
ipsilateral 9 20 1135 1146 B-cancer
supraclavicular 21 36 1147 1162 I-cancer
node 37 41 1163 1167 O
involvement 42 53 1168 1179 O

Mammogram 0 9 1180 1189 O
for 10 13 1190 1193 O
the 14 17 1194 1197 O
unaffected 18 28 1198 1208 O
contralateral 29 42 1209 1222 B-cancer
breast 43 49 1223 1229 I-cancer
is 50 52 1230 1232 O
required 53 61 1233 1241 O
within 62 68 1242 1248 O
12 69 71 1249 1251 B-upper_bound
months 72 78 1252 1258 I-upper_bound
prior 79 84 1259 1264 I-upper_bound
to 85 87 1265 1267 O
registration 88 100 1268 1280 O

Pathologic 0 10 1281 1291 O
confirmation 11 23 1292 1304 O
of 24 26 1305 1307 O
invasive 27 35 1308 1316 O
breast 36 42 1317 1323 B-cancer
cancer 43 49 1324 1330 I-cancer
diagnosed 50 59 1331 1340 O
by 60 62 1341 1343 O
core 63 67 1344 1348 B-treatment
needle 68 74 1349 1355 I-treatment
biopsy 75 81 1356 1362 I-treatment

Patients 0 8 1363 1371 O
with 9 13 1372 1376 O
contralateral 14 27 1377 1390 B-cancer
ductal 28 34 1391 1397 I-cancer
carcinoma 35 44 1398 1407 I-cancer
in 45 47 1408 1410 O
situ 48 52 1411 1415 O
and/or 53 59 1416 1422 O
invasive 60 68 1423 1431 O
breast 69 75 1432 1438 B-cancer
cancer 76 82 1439 1445 I-cancer

Patients 0 8 1446 1454 O
with 9 13 1455 1459 O
multi 14 19 1460 1465 B-cancer
- 19 20 1465 1466 I-cancer
centric 20 27 1466 1473 I-cancer
breast 28 34 1474 1480 I-cancer
cancer 35 41 1481 1487 I-cancer
( 42 43 1488 1489 O
defined 43 50 1489 1496 O
as 51 53 1497 1499 O
more 54 58 1500 1504 O
than 59 63 1505 1509 O
one 64 67 1510 1513 B-lower_bound
lesion 68 74 1514 1520 B-clinical_variable
is 75 77 1521 1523 O
invasive 78 86 1524 1532 B-cancer
breast 87 93 1533 1539 I-cancer
cancer 94 100 1540 1546 I-cancer
in 101 103 1547 1549 O
the 104 107 1550 1553 O
same 108 112 1554 1558 O
breast 113 119 1559 1565 O
separated 120 129 1566 1575 O
by 130 132 1576 1578 O
≥ 133 134 1579 1580 O
2 135 136 1581 1582 B-lower_bound
cm 137 139 1583 1585 I-lower_bound
of 140 142 1586 1588 O
normal 143 149 1589 1595 O
breast 150 156 1596 1602 O
tissue 157 163 1603 1609 O

Surgical 0 8 1610 1618 B-treatment
axillary 9 17 1619 1627 I-treatment
staging 18 25 1628 1635 O
procedure 26 35 1636 1645 O
prior 36 41 1646 1651 O
to 42 44 1652 1654 O
study 45 50 1655 1660 O
entry 51 56 1661 1666 O

Tissue 0 6 1667 1673 O
acquisition 7 18 1674 1685 O
: 18 19 1685 1686 O
Patient 20 27 1687 1694 O
must 28 32 1695 1699 O
agree 33 38 1700 1705 O
to 39 41 1706 1708 O
provide 42 49 1709 1716 O
the 50 53 1717 1720 O
required 54 62 1721 1729 O
research 63 71 1730 1738 O
biopsies 72 80 1739 1747 B-treatment
at 81 83 1748 1750 O
baseline 84 92 1751 1759 O
, 92 93 1759 1760 O
week 94 98 1761 1765 O
4 99 100 1766 1767 O
and 101 104 1768 1771 O
at 105 107 1772 1774 O
surgery 108 115 1775 1782 B-treatment
for 116 119 1783 1786 O
integral 120 128 1787 1795 O
and 129 132 1796 1799 O
integrated 133 143 1800 1810 O
biomarker 144 153 1811 1820 O
and 154 157 1821 1824 O
correlative 158 169 1825 1836 O
studies 170 177 1837 1844 O

Treatment 0 9 1845 1854 B-treatment
for 10 13 1855 1858 O
this 14 18 1859 1863 O
cancer 19 25 1864 1870 B-cancer
including 26 35 1871 1880 O
surgery 36 43 1881 1888 B-treatment
, 43 44 1888 1889 O
radiation 45 54 1890 1899 B-treatment
therapy 55 62 1900 1907 I-treatment
, 62 63 1907 1908 O
chemotherapy 64 76 1909 1921 B-treatment
, 76 77 1921 1922 O
biotherapy 78 88 1923 1933 B-treatment
, 88 89 1933 1934 O
hormonal 90 98 1935 1943 B-treatment
therapy 99 106 1944 1951 I-treatment
or 107 109 1952 1954 O
investigational 110 125 1955 1970 B-treatment
agent 126 131 1971 1976 I-treatment
prior 132 137 1977 1982 O
to 138 140 1983 1985 O
study 141 146 1986 1991 O
entry 147 152 1992 1997 O

Tumor 0 5 1998 2003 B-cancer
estrogen 6 14 2004 2012 B-clinical_variable
receptor 15 23 2013 2021 I-clinical_variable
( 24 25 2022 2023 I-clinical_variable
ER 25 27 2023 2025 I-clinical_variable
) 27 28 2025 2026 I-clinical_variable
Allred 29 35 2027 2033 I-clinical_variable
score 36 41 2034 2039 I-clinical_variable
between 42 49 2040 2047 O
0 50 51 2048 2049 B-lower_bound
- 51 52 2049 2050 O
5 52 53 2050 2051 B-upper_bound
or 54 56 2052 2054 O
HER2 57 61 2055 2059 B-cancer
positive 62 70 2060 2068 O
by 71 73 2069 2071 O
IHC 74 77 2072 2075 B-treatment
( 78 79 2076 2077 O
3 79 80 2077 2078 O
+ 80 81 2078 2079 O
) 81 82 2079 2080 O
or 83 85 2081 2083 O
amplified 86 95 2084 2093 O
by 96 98 2094 2096 O
FISH 99 103 2097 2101 B-clinical_variable
> 104 105 2102 2103 O
2.0 106 109 2104 2107 B-lower_bound

